Skip to content
Home/Companies/Biotech/Apini Therapeutics

Apini Therapeutics

Biotech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Apini Therapeutics?

Apini Therapeutics is currently owned by Northern Gritstone through Northern Gritstone Evergreen (2020 vintage), since 2025.

Hand-verified · updated 2026-06-02

Northern Gritstone
Investor
Northern Gritstone
Northern Gritstone Evergreen · 2020 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive

More from Northern Gritstone Evergreen

Other portfolio companies in the same fund.

AmpliSi
Active
Deep TechUK· 2026
Cytotrait
Active
AgTechUK· 2026
Pixel-Flo
Active
Deep TechUK· 2026
IVFmicro
IVFmicro
Active
MedTechUK· 2025
Literal Labs
Active
AI/MLUK· 2025
OLO Robotics
OLO Robotics
Active
Deep TechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Apini Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Apini Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue